Related Experiment Videos
Nonencapsulated hemoglobin-based red blood cell substitutes: an updated view
1U.S. Department of Agriculture, Agricultural Research Service, Food Animal Protection Research Laboratory, College Station, Texas 77845.
Biotechnology and Applied Biochemistry
|December 1, 1991
Summary
Nonencapsulated hemoglobin (Hb)-based blood substitutes are reviewed, focusing on critical properties like oxygen transport and purity. Ensuring Hb purity through rigorous testing is vital for their safe and effective use.
Area of Science:
- Biomaterials Science
- Hematology
- Biochemistry
Background:
- Nonencapsulated hemoglobin (Hb)-based oxygen carriers (HBOCs) are explored as potential red blood cell substitutes.
- Their development faces challenges related to safety, efficacy, and production.
Purpose of the Study:
- To review the characteristics and properties of nonencapsulated Hb-based materials.
- To examine critical criteria for evaluating HBOCs, including purity assurance.
Main Methods:
- Literature review of Hb-based materials and their properties.
- Analysis of chemical and physical criteria: oxygen dissociation, oxygen carrying capacity, antigenicity, viscosity, and circulatory retention time.
- Examination of methods for Hb purity testing: lipid purity, endotoxin levels, and protein profile.
Main Results:
- Key properties influencing HBOC performance and safety are detailed.
- Hb purity assurance testing is identified as a critical factor.
- Methods for evaluating lipid purity, endotoxin levels, and protein profiles are described.
Conclusions:
- Rigorous purity testing is essential for the development of safe and effective nonencapsulated hemoglobin-based blood substitutes.
- Standardized analytical methods are needed to ensure the quality of Hb solutions for therapeutic applications.